Evidence map›Paper›PMID 40697660›Full record

ReviewFrontiers in pharmacology2025

Application of artificial intelligence large language models in drug target discovery.

Xinyu Liu, Jia Zhang, Xiaoran Wang, Maoda Teng, Guoying Wang, Xiaoming Zhou

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Crosstalk between autophagy and ferroptosis in liver diseases (Review).International journal of molecular medicine · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinyu LiuShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Jia ZhangShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xiaoran WangShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Maoda TengLinyi Central Hospital, Dezhou, China.
Guoying WangThe Second People's Hospital of Dongying, Dongying, China.
Xiaoming ZhouDepartment of Research, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug target discovery is a fundamental aspect of contemporary drug research and development. However, the use of conventional biochemical screening, omics analysis, and related approaches is constrained by substantial technical complexity and significant resource requirements. With the advancement of artificial intelligence-based large language models, notable progress has been achieved in drug target identification. During target mining, large language models with natural language comprehension capabilities can efficiently integrate literature data resources and systematically analyze disease-associated biological pathways and potential targets. Notably, models specifically designed for biomolecular "language" have demonstrated advantages across multiple aspects. The genomics-focused large language model has significantly enhanced the accuracy of pathogenic gene variant identification and gene expression prediction. In transcriptomics, large language models enable comprehensive reconstruction of gene regulatory networks. In proteomics, advancements have been made in protein structure analysis, function prediction, and interaction inference. Additionally, the single-cell multi-omics large language model facilitates data integration across different omics technologies. These technological advancements provide multi-dimensional biological evidence supporting drug target discovery and contribute to a more efficient screening process for candidate targets. The development of these models is generally based on deep neural networks of Transformer architecture, and powerful representation capabilities are obtained through large-scale unsupervised pre-training (such as mask language modeling, autoregressive prediction) combined with task-specific supervised fine-tuning. This review systematically examines recent advancements in the application of large language models in drug target discovery, emphasizing existing technical challenges and potential future research directions.

Indexed as

bioinformaticsdrug target discoverylarge language modelmulti-omics integrationprotein structure prediction

Identifiers

PMID40697660
PMCPMC12279696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.